相关实验视频
Updated: May 31, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
在急性ST段升高心肌梗塞后的血小板成熟度和反应性的变化
Oliver Buchhave Pedersen1,2,3, Peter H Nissen1,3, Leonardo Pasalic4,5
1Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
在ST段升高心肌梗塞 (STEMI) 患者中,不成熟的血小板具有高度反应性,并表达密集的颗粒. 尽管使用抗血小板治疗,这种高反应性仍然存在,这表明它在STEMI结果中起着关键作用.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 血小板生物学 血小板生物学
背景情况:
- 在ST段升高心肌梗塞 (STEMI) 患者中观察到抗血小板治疗的有效性降低.
- 不成熟,高度反应性的血小板的水平增加可能会导致这种治疗效果降低.
研究的目的:
- 为了研究急性STEMI后患者血小板成熟度和反应性的变化.
- 描述STEMI患者未成熟血小板的反应性和密集颗粒表达.
主要方法:
- 使用SYTO-13进行多色流细胞计,以评估血小板成熟度.
- 测量了全血血小板聚合,血清血红素B2水平,以及标准的不成熟血小板标志物.
- 从STEMI患者在基线 (24小时内) 和2至3个月后期收集的血液样本.
主要成果:
- 与成熟和总血小板种群相比,不成熟的血小板在基线和随访时表现出始终更高的反应性 (P < .05).
- 在不成熟的血小板上观察到CD63 (密集颗粒标记物) 的高表达,从基线到随访没有显著变化 (P > .24).
- 在标准的不成熟血小板标志物和CD63表达 (rho 0.320.62,P <.05) 之间发现了显著的正相关性.
结论:
- 未成熟的血小板构成了高度反应的亚群,对STEMI的整体血小板反应性至关重要.
- 尽管在STEMI患者中进行了标准抗血小板治疗,但与密集颗粒表达相关的高不成熟血小板反应性仍然存在.
更多相关视频
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
相关概念视频
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Clot Retraction and Fibrinolysis
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...